OrbiMed Capital LLC
- SEC CIK
- 0001157524
No open-market purchases or sales filed in the past year.
Current role at each company
- PRLD Prelude Therapeutics IncDirector, 10% Owneras of Apr 23, 2026
- SPRY ARS Pharmaceuticals, Inc.Directoras of Aug 28, 2024
- KNTE Kinnate Biopharma Inc.Director, 10% Owneras of Apr 5, 2024
- SRRA Sierra Oncology, Inc.Director, 10% Owneras of Jul 1, 2022
- ARQT Arcutis Biotherapeutics, Inc.10% Owneras of Jun 28, 2022
Show 3 more companies
- PMVP PMV Pharmaceuticals, Inc.10% Owneras of Mar 31, 2022
- RPTX Repare Therapeutics Inc.Directoras of Sep 8, 2021
- ELVN Enliven Therapeutics, Inc.Director, 10% Owneras of Jul 16, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists OrbiMed Capital LLC as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
PRLD Prelude Therapeutics Inc
Director, 10% Owner2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 23, 2026 (view filing)6:48 PM ET | Apr 21 | 2 days | OrbiMed Advisors LLC and 3 othersDirector, 10% Owner | PPurchase | +2.82M | $4.44 | +$12.5M | New position1.13M after | 2 lotsDuplicate filing |
| May 24, 2023 (view filing)5:09 PM ET | May 22 | 2 days | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +869.6K | $5.75 | +$5.00M | +9.4%10.1M after | Duplicate filing |
SPRY ARS Pharmaceuticals, Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 28, 2024 (view filing)4:26 PM ET | Aug 26 | 2 days | OrbiMed Advisors LLC and 2 othersDirector | SSale | −83.7K | $13.00 | −$1.09M | −100.0%0 after | Duplicate filing |
| Aug 23, 2024 (view filing)6:38 PM ET | Aug 21-23 | 2 days | OrbiMed Advisors LLC and 2 othersDirector | SSale | −868.7K | $13.24 | −$11.5M | −91.2%83.7K after | 4 lotsDuplicate filing |
| Aug 31, 2023 (view filing)5:26 PM ET | Aug 29 | 2 days | OrbiMed Advisors LLC and 2 othersDirector | PPurchase | +500.0K | $6.20 | +$3.10M | +6.6%8.02M after | Duplicate filing |
KNTE Kinnate Biopharma Inc.
Director, 10% Owner3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 8, 2023 (view filing)5:22 PM ET | May 4-5 | 4 days | OrbiMed Advisors LLC and 6 othersDirector, 10% Owner | PPurchase | +1.46M | $2.80 | +$4.09M | New position1.37M after | 5 lotsDuplicate filing |
| May 2, 2023 (view filing)9:34 PM ET | Apr 28-May 2 | 4 days | OrbiMed Advisors LLC and 6 othersDirector, 10% Owner | PPurchase | +1.41M | $2.61 | +$3.67M | New position794.4K after | 9 lotsDuplicate filing |
| Feb 15, 2022 (view filing)9:42 PM ET | Feb 11-15 | 4 days | OrbiMed Advisors LLC and 3 othersDirector | PPurchase | +195.7K | $10.17 | +$1.99M | +5.9%3.51M after | 4 lotsDuplicate filing |
ARQT Arcutis Biotherapeutics, Inc.
10% Owner2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 28, 2022 (view filing)4:29 PM ET | Jun 24 | 4 days | OrbiMed Advisors LLC and 2 others10% Owner | SSale | −342.0K | $21.31 | −$7.29M | −45.2%415.1K after | 2 lots |
| Apr 8, 2022 (view filing)6:06 PM ET | Apr 6-8 | 2 days | OrbiMed Advisors LLC and 2 others10% Owner | SSale | −878.2K | $20.68 | −$18.2M | −66.1%451.1K after | 6 lots |
PMVP PMV Pharmaceuticals, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2022 (view filing)5:30 PM ET | Mar 29-31 | 2 days | OrbiMed Advisors LLC and 3 others10% Owner | SSale | −474.5K | $21.63 | −$10.3M | −100.0%0 after | 3 lots |
RPTX Repare Therapeutics Inc.
Director5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 8, 2021 (view filing)6:18 PM ET | Sep 3-7 | 5 days | OrbiMed Advisors LLC and 2 othersDirector | SSale | −8.08K | $33.99 | −$274.8K | −7.8%96.2K after | 4 lotsDuplicate filing |
| Sep 2, 2021 (view filing)8:27 PM ET | Aug 31-Sep 2 | 2 days | OrbiMed Advisors LLC and 2 othersDirector | SSale | −37.9K | $34.08 | −$1.29M | −28.2%96.4K after | 6 lotsDuplicate filing |
| Aug 30, 2021 (view filing)6:37 PM ET | Aug 26-30 | 4 days | OrbiMed Advisors LLC and 2 othersDirector | SSale | −18.1K | $34.07 | −$615.7K | −15.6%97.5K after | 6 lotsDuplicate filing |
| Aug 25, 2021 (view filing)8:43 PM ET | Aug 23-25 | 2 days | OrbiMed Advisors LLC and 2 othersDirector | SSale | −18.2K | $34.17 | −$622.4K | −15.7%98.1K after | 6 lotsDuplicate filing |
| Aug 19, 2021 (view filing)8:55 PM ET | Aug 17-18 | 2 days | OrbiMed Advisors LLC and 2 othersDirector | SSale | −20.3K | $34.10 | −$693.2K | −17.1%98.6K after | 4 lotsDuplicate filing |
ELVN Enliven Therapeutics, Inc.
Director, 10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 16, 2021 (view filing)4:27 PM ET | Jul 16 | Same day | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +1.67M | $6.00 | +$10.0M | New position1.67M after |